BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29729251)

  • 1. Point mutations in the tri-helix bundle of the M-domain of cardiac myosin binding protein-C influence systolic duration and delay cardiac relaxation.
    van Dijk SJ; Kooiker KB; Napierski NC; Touma KD; Mazzalupo S; Harris SP
    J Mol Cell Cardiol; 2018 Jun; 119():116-124. PubMed ID: 29729251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position.
    Mun JY; Kensler RW; Harris SP; Craig R
    J Mol Cell Cardiol; 2016 Feb; 91():141-7. PubMed ID: 26718724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal cardiac contraction in mice lacking the proline-alanine rich region and C1 domain of cardiac myosin binding protein C.
    van Dijk SJ; Witt CC; Harris SP
    J Mol Cell Cardiol; 2015 Nov; 88():124-32. PubMed ID: 26455481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of in vivo left ventricular [correction] contraction/relaxation kinetics by myosin binding protein C: protein kinase A phosphorylation dependent and independent regulation.
    Nagayama T; Takimoto E; Sadayappan S; Mudd JO; Seidman JG; Robbins J; Kass DA
    Circulation; 2007 Nov; 116(21):2399-408. PubMed ID: 17984378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gain-of-function mutation in the M-domain of cardiac myosin-binding protein-C increases binding to actin.
    Bezold KL; Shaffer JF; Khosa JK; Hoye ER; Harris SP
    J Biol Chem; 2013 Jul; 288(30):21496-505. PubMed ID: 23782699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes.
    Pohlmann L; Kröger I; Vignier N; Schlossarek S; Krämer E; Coirault C; Sultan KR; El-Armouche A; Winegrad S; Eschenhagen T; Carrier L
    Circ Res; 2007 Oct; 101(9):928-38. PubMed ID: 17823372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cardiac myosin-binding protein C restricts actin structural dynamics in a cooperative and phosphorylation-sensitive manner.
    Bunch TA; Kanassatega RS; Lepak VC; Colson BA
    J Biol Chem; 2019 Nov; 294(44):16228-16240. PubMed ID: 31519753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac myosin-binding protein C N-terminal interactions with myosin and actin filaments: Opposite effects of phosphorylation and M-domain mutations.
    Wong FL; Bunch TA; Lepak VC; Steedman AL; Colson BA
    J Mol Cell Cardiol; 2024 Jan; 186():125-137. PubMed ID: 38008210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy.
    Kuster DWD; Lynch TL; Barefield DY; Sivaguru M; Kuffel G; Zilliox MJ; Lee KH; Craig R; Namakkal-Soorappan R; Sadayappan S
    Cardiovasc Res; 2019 Dec; 115(14):1986-1997. PubMed ID: 31050699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino terminus of cardiac myosin binding protein-C regulates cardiac contractility.
    Lynch TL; Kumar M; McNamara JW; Kuster DWD; Sivaguru M; Singh RR; Previs MJ; Lee KH; Kuffel G; Zilliox MJ; Lin BL; Ma W; Gibson AM; Blaxall BC; Nieman ML; Lorenz JN; Leichter DM; Leary OP; Janssen PML; de Tombe PP; Gilbert RJ; Craig R; Irving T; Warshaw DM; Sadayappan S
    J Mol Cell Cardiol; 2021 Jul; 156():33-44. PubMed ID: 33781820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.
    De Lange WJ; Grimes AC; Hegge LF; Spring AM; Brost TM; Ralphe JC
    J Gen Physiol; 2013 Sep; 142(3):241-55. PubMed ID: 23980194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro.
    Govindan S; Sarkey J; Ji X; Sundaresan NR; Gupta MP; de Tombe PP; Sadayappan S
    J Muscle Res Cell Motil; 2012 May; 33(1):17-30. PubMed ID: 22527638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function.
    Rosas PC; Liu Y; Abdalla MI; Thomas CM; Kidwell DT; Dusio GF; Mukhopadhyay D; Kumar R; Baker KM; Mitchell BM; Powers PA; Fitzsimons DP; Patel BG; Warren CM; Solaro RJ; Moss RL; Tong CW
    Circ Heart Fail; 2015 May; 8(3):582-94. PubMed ID: 25740839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation.
    Harris SP; Belknap B; Van Sciver RE; White HD; Galkin VE
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1558-63. PubMed ID: 26831109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel "Cut and Paste" Method for In Situ Replacement of cMyBP-C Reveals a New Role for cMyBP-C in the Regulation of Contractile Oscillations.
    Napierski NC; Granger K; Langlais PR; Moran HR; Strom J; Touma K; Harris SP
    Circ Res; 2020 Mar; 126(6):737-749. PubMed ID: 32078438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the critical residues responsible for cardiac myosin binding protein C's interactions.
    Bhuiyan MS; Gulick J; Osinska H; Gupta M; Robbins J
    J Mol Cell Cardiol; 2012 Dec; 53(6):838-47. PubMed ID: 22982234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slowing of contractile kinetics by myosin-binding protein C can be explained by its cooperative binding to the thin filament.
    Wang C; Schwan J; Campbell SG
    J Mol Cell Cardiol; 2016 Jul; 96():2-10. PubMed ID: 26454159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo definition of cardiac myosin-binding protein C's critical interactions with myosin.
    Bhuiyan MS; McLendon P; James J; Osinska H; Gulick J; Bhandary B; Lorenz JN; Robbins J
    Pflugers Arch; 2016 Oct; 468(10):1685-95. PubMed ID: 27568194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation.
    Stelzer JE; Patel JR; Walker JW; Moss RL
    Circ Res; 2007 Aug; 101(5):503-11. PubMed ID: 17641226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo left ventricular functional capacity is compromised in cMyBP-C null mice.
    Brickson S; Fitzsimons DP; Pereira L; Hacker T; Valdivia H; Moss RL
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1747-54. PubMed ID: 17122190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.